Douglas C. Hanson

2.3k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Douglas C. Hanson is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Douglas C. Hanson has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Douglas C. Hanson's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Ion channel regulation and function (8 papers) and Air Traffic Management and Optimization (5 papers). Douglas C. Hanson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Ion channel regulation and function (8 papers) and Air Traffic Management and Optimization (5 papers). Douglas C. Hanson collaborates with scholars based in United States, Germany and Russia. Douglas C. Hanson's co-authors include George A. Gutman, Jayashree Aiyar, K. George Chandy, Robert J. Mather, Stephan Grissmer, Verne N. Schumaker, D. D. Auperin, A. N. Nguyen, Michael J. Karmilowicz and Juan Yguerabide and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Neuron.

In The Last Decade

Douglas C. Hanson

37 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.

1994 692 citations Stephan Grissmer, A. N. Nguyen et al. Molecular Pharmacology profile →

Peers

Countries citing papers authored by Douglas C. Hanson

Since Specialization

Citations

This map shows the geographic impact of Douglas C. Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C. Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C. Hanson more than expected).

Fields of papers citing papers by Douglas C. Hanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas C. Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C. Hanson. The network helps show where Douglas C. Hanson may publish in the future.

Co-authorship network of co-authors of Douglas C. Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas C. Hanson. A scholar is included among the top collaborators of Douglas C. Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas C. Hanson. Douglas C. Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Electrochemical Substrate and Assay for Esterolytic Activity of Human White Blood Cells 2017 ·Analytical Chemistry ·Douglas C. Hanson, (unknown), Stanton F. McHardy, Andrew N. Fleischman, Waldemar Górski	12
2	Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse 2008 ·Cancer Immunology Immunotherapy ·Alain Vicari, (unknown), Ningli Zhang, (unknown), (unknown), Douglas C. Hanson, Risini D. Weeratna, Arthur Μ. Krieg	100
3	Preclinical in vitro characterization of anti-CTLA4 therapeutic antibody CP-675,206. 2004 ·Cancer Research ·Douglas C. Hanson, Paul C. Canniff, Michael J. Primiano, Carol Donovan, Joseph P. Gardner, Edward J. Natoli, Rodney Morgan, Robert J. Mather, David H. Singleton, (unknown), Mark J. Neveu, Glenn C. Andrews, (unknown), Eileen A. Elliott, Vahe Bedian	30
4	CP-675,206 anti-CTLA4 antibody clinical candidate enhances IL-2 production in cancer patient T cells in vitro regardless of tumor type or stage of disease 2004 ·Paul C. Canniff, Carol Donovan, (unknown), (unknown), Vahe Bedian, Steven H. Bernstein, Douglas C. Hanson	11
5	UK‐78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage‐gated potassium channel and inhibits human T cell activation 1999 ·British Journal of Pharmacology ·Douglas C. Hanson, Angela Nguyen, Robert J. Mather, Heiko Rauer, Kevin M. Koch, Laurence E. Burgess, James P. Rizzi, Carol Donovan, (unknown), Paul C. Canniff, Ann Cunningham, (unknown), (unknown), John C. Kath, George A. Gutman, Michael D. Cahalan, Stephan Grissmer, (unknown)	62
6	Ion channel modulation as a drug discovery target in inflammatory diseases 1996 ·Inflammation Research ·Douglas C. Hanson, Kevin M. Koch	1
7	Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation. 1996 ·Molecular Pharmacology ·Angela Nguyen, John C. Kath, Douglas C. Hanson, Michael S. Biggers, Paul C. Canniff, Carol Donovan, Robert J. Mather, (unknown), Heiko Rauer, Jayashree Aiyar, A. Lepple-Wienhues, George A. Gutman, Stephan Grissmer, Michael D. Cahalan, K. George Chandy	93
8	Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins 1995 ·Neuron ·Jayashree Aiyar, Jane M. Withka, James P. Rizzi, David H. Singleton, Glenn C. Andrews, Lu‐Yin Lin, James G. Boyd, Douglas C. Hanson, Mariella Simon, B Dethlefs, (unknown), James E. Hall, George A. Gutman, K. George Chandy	221
9	The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant 1995 ·Journal of Medicinal Chemistry ·Kevin M. Koch, M F Newborg, Douglas C. Hanson, Kelvin Cooper, Richard M. Shepard, Michael Biehl, Michael S. Biggers, (unknown), Gary R. Schulte	3
10	Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. breakdown → 1994 ·Molecular Pharmacology ·Stephan Grissmer, A. N. Nguyen, Jayashree Aiyar, Douglas C. Hanson, Robert J. Mather, George A. Gutman, Michael J. Karmilowicz, D. D. Auperin, K. George Chandy	692
11	Possible Role of IL-1 in Arthritis: Effects of Prostaglandins in the Regulation of IL-1 Synthesis and Actions 1993 ·Birkhäuser Basel eBooks ·Ivan G. Otterness, Douglas C. Hanson, Marcia L. Bliven	1
12	Dynamic aspects of antibody structure 1991 ·Molecular Immunology ·Verne N. Schumaker, Martin L. Phillips, Douglas C. Hanson	18
13	Inhibition of interleukin 1 synthesis by tenidap: A new drug for arthritis 1991 ·Cytokine ·Ivan G. Otterness, Marcia L. Bliven, James T. Downs, Edward J. Natoli, Douglas C. Hanson	42
14	CD4-CD8- T cells from mice with collagen arthritis display aberrant expression of type l K+ channels. 1990 ·The Journal of Immunology ·Stephan Grissmer, Douglas C. Hanson, Edward J. Natoli, Michael D. Cahalan, K. George Chandy	13
15	Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals 1990 ·Clinical Immunology and Immunopathology ·Peter H. Schur, Deh‐Ming Chang, (unknown), (unknown), Douglas C. Hanson	27
16	The pharmacologic regulation of interleukin-1 production: The role of prostaglandins 1988 ·Cellular Immunology ·Ivan G. Otterness, Marcia L. Bliven, James D. Eskra, (unknown), Douglas C. Hanson	49
17	Segmental flexibility of the C1q subcomponent of human complement and its possible role in the immune response. 1985 ·Journal of Biological Chemistry ·Douglas C. Hanson, Richard Siegel, Verne N. Schumaker	14
18	Chemistry of singlet oxygen. 47. 9,10-Dicyanoanthracene-sensitized photooxygenation of alkyl-substituted olefins 1984 ·Journal of the American Chemical Society ·(unknown), (unknown), Thomas Goyne, Douglas C. Hanson, (unknown), (unknown), Christopher S. Foote	51
19	Flight Phase Status Monitor Study. Phase I. Systems Concepts 1984 ·Defense Technical Information Center (DTIC) ·(unknown), (unknown), Douglas C. Hanson, Cláudio Rossi	0
20	Comparison of Histocompatibility Antigens on Cultured Human Tumor Cells and Fibroblasts by Quantitative Antibody Absorption and Sensitivity to Cell-Mediated Cytotoxicity 2 3 1976 ·JNCI Journal of the National Cancer Institute ·Sidney H. Golub, Douglas C. Hanson, (unknown), Donald L. Morton, Michele Pellegrino, Soldano Ferrone	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact